An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Conditions
Progressive Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Tejaswini Kulkarni)University of Southern California, Los Angeles, California, United States
Contact: Principal Investigator (Toby Maher)University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Joyce Lee)Contact: Principal Investigator (Joyce Lee, MD)Renstar Medical Research, Ocala, Florida, United States
Contact: Study coordinator (Raj Karunakara)Contact: Principal Investigator (Raj Karunakara, MD)Piedmont Healthcare, Inc., Atlanta, Georgia, United States
Contact: Study coordinator (Amy Case)Contact: Principal Investigator (Amy Case, MD)The University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Study coordinator (Mark Hamblin, MD)Contact: Principal Investigator (Mark Hamblin, MD)University of Maryland, Baltimore, Maryland, United States
Contact: Principal Investigator (Edward Britt)Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Matthew Lammi, MD)Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Andrew Limper)Contact: Study coordinator (Sam Nascak)Contact: Principal Investigator (Andrew Limper, MD)Hannibal Regional Healthcare System, Inc., Hannibal, Missouri, United States
Contact: Study coordinator (Humam Farah, MD)Contact: Principal Investigator (Humam Farah, MD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Maria Padilla)Contact: Principal Investigator (Maria Padilla, MD)Columbia University, New York, New York, United States
Contact: Study coordinator (Claire McGroder)Contact: Principal Investigator (Claire McGroder, MD)Piedmont HealthCare, PA, Statesville, North Carolina, United States
Contact: Study coordinator (Jose Perez)Contact: Principal Investigator (Jose Perez, MD)Southeastern Research Center, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Jason Thomason, MD)University of Cincinnati, Cincinnati, Ohio, United States
Contact: Study coordinator (Nishant Gupta)Contact: Principal Investigator (Nishant Gupta, MD)Summit Health, Bend, Oregon, United States
Contact: Study coordinator (Jeremy Feldman, MD)Contact: Principal Investigator (Jeremy Feldman, MD)Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Ross Summer)Contact: Principal Investigator (Ross Summer, MD)Temple University Hospital, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Gerard Criner, MD)Contact: Principal Investigator (Gerard Criner, MD)Lowcountry Lung and Critical Care, PA, Charleston, South Carolina, United States
Contact: Study coordinator (Thomas Kaelin, Jr, DO)Contact: Principal Investigator (Thomas Kaelin, Jr., DO)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Study coordinator (Timothy Whelan)Contact: Principal Investigator (Timothy Whelan, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Justin Hewlett, MD)Contact: Principal Investigator (Justin Hewlett, MD)El Paso Pulmonary Association, P.A., El Paso, Texas, United States
Contact: Study coordinator (Carlo Hatem, MD)Contact: Principal Investigator (Carlo Hatem, MD)Intermountain Medical Center, Murray, Utah, United States
Contact: Study coordinator (Peter Crossno, MD)Contact: Principal Investigator (Peter Crossno, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Mary Beth Scholand, MD)Inova Healthcare, Falls Church, Virginia, United States
Contact: Principal Investigator (Vikramjit Khangoora)Westmead Hospital, Westmead, New South Wales, Australia
Contact: Principal Investigator (John Wheatley)The Queen Elizabeth Hospital, Woodville South, South Australia, Australia
Royal Prince Alfred Hospital, Camperdown, Australia
Contact: Principal Investigator (Tamera Corte)The Prince Charles Hospital (TPCH), Chermside, Australia
Contact: Principal Investigator (Peter Hopkins)Lung & Sleep Victoria, Footscray, Australia
Contact: Study coordinator (Ian Glaspole)Contact: Principal Investigator (Ian Glaspole)Respiratory Clinical Trials PTY Ltd, Kent Town, Australia
Contact: Principal Investigator (Michael Chia)Nepean Lung & Sleep, Kingston, Australia
Contact: Study coordinator (Donald Lee)Contact: Principal Investigator (Donald Lee)Univ of Western Australia / Institute for Respiratory Health, Nedlands, Australia
Contact: Principal Investigator (Vidya Navaratnam)John Hunter Hospital, New Lambton Heights, Australia
Contact: Study coordinator (Christopher Grainge) · christopher.grainge@health.nsw.gov.au · 000-000-000Contact: Principal Investigator (Christopher Grainge)Dynamic Drug Advancement, Ajax, Ontario, Canada
Contact: Principal Investigator (George Philteos)Research Institute McGill University Health Center, Montreal, Quebec, Canada
Contact: Principal Investigator (Deborah Assayag)CIC Mauricie, Trois-Rivières, Quebec, Canada
Contact: Principal Investigator (Emilie Millaire)Centre for Lung Health, Vancouver, Vancouver, Canada
Contact: Principal Investigator (Daniel Marinescu)Fakultni Thomayerove nemocnice, Praha Klanovice, Czechia
Contact: Principal Investigator (Martina Sterclova)University of Montpellier, Montrevel-en-Bresse, Montpellier, France
Contact: Study coordinator (Arnaud Bourdin)Contact: Principal Investigator (Arnaud Bourdin)Centre Hospitalier Universitaire d'Angers, Angers, France
Contact: Study coordinator (Frederic Gagnadoux, MD)Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany
Contact: Principal Investigator (Jonas Schupp)Fondazione IRCCS Policlinico San Matteo - UOC Pneumologia, Pavia, Lombardy, Italy
Contact: Study coordinator (Angelo Guido Corsico, MD)St Antonius Hospital, Nieuwegein, Netherlands
Contact: Principal Investigator (Marcel Veltkamp)Greenlane Clinical Centre, Auckland, Auckland, New Zealand
Contact: Principal Investigator (Margaret Wilsher)Bay of Plenty Clinical Trials Unit, Tauranga, Tauranga, New Zealand
Contact: Principal Investigator (Suzanne Poole)Dunedin Hospital, Dunedin, New Zealand
Waikato Hospital, Hamilton, New Zealand
Contact: Principal Investigator (Catherina Chang)Uniwersyteckie Centrum Kliniczne, Gdansk, Poland
Contact: Study coordinator (Amelia Szymanowska-Narloch, MD)Department of Pneumology of the University Hospital No 1, Lodz, Poland
Contact: Study coordinator (Wojciech Piotrowski, MD, PhD)Hospital Gregorio Marañon, Madrid, Madrid, Spain
Contact: Principal Investigator (Luis Puente Maestu)Hull University Teaching Hospital, Cottingham, East Yorkshire, United Kingdom
Contact: Principal Investigator (Simon Hart)Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom
Contact: Study coordinator (Helen Parfrey, MD)Leicester Biomedical Research Centre, Leicester, United Kingdom
Contact: Principal Investigator (Charlotte Swales)
Study leads
Avalyn Pharma, Inc.
Study Director
Avalyn Pharma Inc.